These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20874490)

  • 1. Association of the pentanucleotide repeat polymorphism in NOS2 promoter region with susceptibility to migraine in a Chinese population.
    Jia S; Ni J; Chen S; Jiang Y; Dong W; Gao Y
    DNA Cell Biol; 2011 Feb; 30(2):117-22. PubMed ID: 20874490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of the allelic frequency of a NOS2A promoter microsatellite in human populations: assessment of the NOS2A gene and predisposition to infectious disease.
    Xu W; Humphries S; Tomita M; Okuyama T; Matsuki M; Burgner D; Kwiatkowski D; Liu L; Charles IG
    Nitric Oxide; 2000 Aug; 4(4):379-83. PubMed ID: 10944422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The (CCTTT) n pentanucleotide repeat polymorphism in the inducible nitric oxide synthase gene promoter and the risk of psoriasis in Taiwanese.
    Chang YC; Wu WM; Huang YH; Chung WH; Tsai HY; Hsu LA
    Arch Dermatol Res; 2015 Jul; 307(5):425-32. PubMed ID: 25663087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain.
    Gonzalez-Gay MA; Llorca J; Sanchez E; Lopez-Nevot MA; Amoli MM; Garcia-Porrua C; Ollier WE; Martin J
    Rheumatology (Oxford); 2004 Sep; 43(9):1182-5. PubMed ID: 15226517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for involvement of the human inducible nitric oxide synthase (iNOS) gene in susceptibility to typical migraine.
    Lea RA; Curtain RP; Shepherd AG; Brimage PJ; Griffiths LR
    Am J Med Genet; 2001 Jan; 105(1):110-3. PubMed ID: 11424980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association analysis of TNFRSF1B polymorphism with susceptibility for migraine in the Chinese Han population.
    Dong W; Jia S; Ye X; Ni J
    J Clin Neurosci; 2012 May; 19(5):750-2. PubMed ID: 22342236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible nitric oxide synthase gene polymorphisms are associated with a risk of nephritis in Henoch-Schönlein purpura children.
    Jiang J; Duan W; Shang X; Wang H; Gao Y; Tian P; Zhou Q
    Eur J Pediatr; 2017 Aug; 176(8):1035-1045. PubMed ID: 28593405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of MTHFR C677T polymorphism with susceptibility to migraine in the Chinese population.
    An XK; Lu CX; Ma QL; Zhang XR; Burgunder JM; Lin Q; Qu HL
    Neurosci Lett; 2013 Aug; 549():78-81. PubMed ID: 23811028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between NOS2 pentanucleotide repeat polymorphism and asthma phenotypes or exhaled nitric oxide concentration.
    Leung TF; Liu EK; Li CY; Chan IH; Yung E; Lam CW; Wong GW
    Pediatr Pulmonol; 2006 Jul; 41(7):649-55. PubMed ID: 16703578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between (CCTTT)n repeat polymorphism in NOS2 promoter and asthma exacerbations.
    Hirai K; Shirai T; Suzuki M; Shimomura T; Itoh K
    J Allergy Clin Immunol; 2018 Aug; 142(2):663-665.e3. PubMed ID: 29518423
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis.
    Gonzalez-Gay MA; Oliver J; Sanchez E; Garcia-Porrua C; Paco L; Lopez-Nevot MA; Ollier WE; Martin J
    J Rheumatol; 2005 Nov; 32(11):2178-82. PubMed ID: 16265698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCTTT pentanucleotide repeats in inducible nitric oxide synthase gene expression in patients with pulmonary arterial hypertension.
    Baloira Villar A; Pousada Fernández G; Vilariño Pombo C; Núñez Fernández M; Cifrián Martínez J; Valverde Pérez D
    Arch Bronconeumol; 2014 Apr; 50(4):141-5. PubMed ID: 24439467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite polymorphism in the heme oxygenase-1 gene promoter and the risk of psoriasis in Taiwanese.
    Chang YC; Wu WM; Tsai HY; Hsu LA
    Arch Dermatol Res; 2012 Nov; 304(9):739-44. PubMed ID: 22965812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies.
    Xu W; Liu L; Emson P; Harrington CR; McKeith IG; Perry RH; Morris CM; Charles IG
    Neuroreport; 2000 Feb; 11(2):297-9. PubMed ID: 10674474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the promoter region of iNOS predispose to rheumatoid arthritis in south Indian Tamils.
    Negi VS; Mariaselvam CM; Misra DP; Muralidharan N; Fortier C; Charron D; Krishnamoorthy R; Tamouza R
    Int J Immunogenet; 2017 Jun; 44(3):114-121. PubMed ID: 28374504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between TNFSF10 polymorphism and migraine susceptibility in a Chinese population.
    Jia S; Dong W; Zhou X; Chen Z; Yun W
    J Int Med Res; 2015 Jun; 43(3):326-31. PubMed ID: 25712717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of migraine GWAS susceptibility loci in Chinese Han population.
    Fan X; Wang J; Fan W; Chen L; Gui B; Tan G; Zhou J
    Headache; 2014 Apr; 54(4):709-15. PubMed ID: 24666033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus.
    López-Nevot MA; Ramal L; Jiménez-Alonso J; Martín J
    Rheumatology (Oxford); 2003 Jan; 42(1):113-6. PubMed ID: 12509623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans.
    Oates JC; Levesque MC; Hobbs MR; Smith EG; Molano ID; Page GP; Hill BS; Weinberg JB; Cooper GS; Gilkeson GS
    J Rheumatol; 2003 Jan; 30(1):60-7. PubMed ID: 12508391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evidences of a NOS2A protective effect from relapsing-remitting multiple sclerosis.
    Manna I; Liguori M; Valentino P; Condino F; La Russa A; Clodomiro A; Nisticò R; Di Palma G; Quattrone A
    J Neurol Sci; 2008 Jan; 264(1-2):112-7. PubMed ID: 17854833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.